Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Pozycja w akcjach #31074
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Cena akcji
$0.404
Kapitalizacja rynkowa
$14.28M
Zmiana (1 dzień)
-10.42%
Zmiana (1 rok)
-67.68%
Kraj
IL
Handel NeuroSense Therapeutics Ltd. (NRSN)

Kategoria

Historia ceny akcji dla NeuroSense Therapeutics Ltd. (NRSN)
Najwyższa cena zamknięcia: $0.47 dnia 2026-08-01

Najniższa cena zamknięcia: $3.04 dnia 2021-12-01
Historia cen akcji firmy NeuroSense Therapeutics Ltd. od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -1.04%
2025 -17.69%
2024 31.68%
2023 -42.23%
2022 -51.82%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$529.92 35.92%
US
$1.01K 52.16%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE